Clinical Implication of Atrial Fibrillation Detection Using Wearable Device in Patients With Cryptogenic Stroke - The Comparison Between Short-term Continuous Patch and Long-term Discontinuous Monitoring
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Atrial Fibrillation
- Sponsor
- Ewha Womans University Mokdong Hospital
- Enrollment
- 600
- Locations
- 9
- Primary Endpoint
- Atrial fibrillation detection rate
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
It is known that atrial fibrillation after stroke significantly increases the risk of stroke or systemic embolism. Accordingly, efforts have been made to detect hidden atrial fibrillation and apply treatment using anticoagulants instead of antiplatelet agents. The conventional method used to screen for atrial fibrillation in stroke patients who did not have atrial fibrillation at first admission is 24-hour Holter monitoring. This study will compare the detection rate of atrial fibrillation with discontinuous ECG monitoring three times a day and 72 hours of single-lead ECG patch monitoring compared with the conventional Holter test.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Newly diagnosed brain infarction
- •No history and diagnosis of atrial fibrillation at the time of admission
- •Rejected implantable loop recorder
- •Informed consent
Exclusion Criteria
- •Cannot use KardiaMobile system alone or with the help of others
Outcomes
Primary Outcomes
Atrial fibrillation detection rate
Time Frame: Until 1 year after stroke
Compare detection rates of each arms
Secondary Outcomes
- Major adverse cardiac and cerebrovascular event(Until 1 year after stroke)
- Recurrent stroke(Until 1 year after stroke)